Publications
126
Citations
3,363
Est. group size
—
Recurring co-author estimate
Active years
61
Publishing since 1966
Randall J. Roper studies Down syndrome, a genetic condition caused by an extra copy of chromosome 21, using mouse models to understand how it affects the body. Much of the work focuses on how the extra genes (especially one called Dyrk1a) impair bone and skeletal development, often examining differences between males and females. The research also explores related topics such as immune dysfunction and potential drug treatments.
Publication activity has been fairly steady over the past decade, averaging around four to six papers per year with some year-to-year variation.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Mouse Models of Down Syndrome
2025
- Skeletal health in DYRK1A syndrome
Frontiers in Neuroscience · 2024
- Early Chronic Fluoxetine Treatment of Ts65Dn Mice Rescues Synaptic Vesicular Deficits and Prevents Aberrant Proteomic Alterations
Genes · 2024
- Sex-specific trisomic <i>Dyrk1a</i>-related skeletal phenotypes during development in a Down syndrome model
Disease Models & Mechanisms · 2024
- Compromised femoral and lumbovertebral bone in the Dp(16)1Yey Down syndrome mouse model
Bone · 2024
- Sex specific emergence of trisomic <i>Dyrk1a</i> -related skeletal phenotypes in the development of a Down syndrome mouse model
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Genetic dissection of triplicated chromosome 21 orthologs yields varying skeletal traits in Down syndrome model mice
Disease Models & Mechanisms · 2023
- Review for "Visual discrimination and inhibitory control deficits in mouse models of Down syndrome: A pilot study using rodent touchscreen technology"
2022
- Review for "Visual discrimination and inhibitory control deficits in mouse models of Down syndrome: A pilot study using rodent touchscreen technology"
2022
- Increased dosage and treatment time of Epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse models
PLoS ONE · 2022
- Specific Susceptibility to COVID-19 in Adults with Down Syndrome
NeuroMolecular Medicine · 2021
- Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome
Frontiers in Immunology · 2021
- Current Analysis of Skeletal Phenotypes in Down Syndrome
Current Osteoporosis Reports · 2021
- Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome
NeuroMolecular Medicine · 2021
- Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome
NeuroMolecular Medicine · 2021
- IUScholarWorks (Indiana University)×5
- NeuroMolecular Medicine×3
- Bone×3
- PMC×3
- bioRxiv (Cold Spring Harbor Laboratory)×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile